Skip to main content

Web Exclusives

FDA Updates

Nivolumab Approved for Patients with Relapsed, Refractory Classical Hodgkin Lymphoma

FDA Updates

Lenvatinib Approved for Use with Everolimus for Treating Advanced Renal Cell Carcinoma

“Newer” Ovarian Cancer Genes and Option of Risk-Reducing Salpingo-Oophorectomy

Cristi Radford, MS, CGC

FDA Updates

Venclexta FDA Approved for Patients with CLL

FDA Updates

FDA Approves Defitelio for Patients with Rare Disorder After HSCT

FDA Updates

FDA Enhances Warnings for Serious Risks of Opioid Analgesics Abuse

FDA Updates

Crizotinib Receives Expanded FDA-Approval to Treat Patients with Rare NSCLC

FDA Updates

FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer

Practical Issues in Pharmacy Management

ASHP Foundation Forecast Provides Actionable Recommendations for Pharmacy Leaders

FDA Updates

FDA Approves Bridion to Reverse Effects of Neuromuscular Blocking Drugs Used During Surgery

Page 33 of 43
Results 321 - 330 of 425